Abstract
Deep vein thrombosis (DVT), with its complications, is a common, serious and potentially fatal disease; it aggravates the course of patients undergoing elective surgery, even more so in case of trauma; considering its frequently binding and urgent nature, it has to be specifically prevented.
Similar content being viewed by others
Bibliografia
Geerts WH, Bergqvist D, Pineo GF et al. (2008) Prevention of venous thromboembolism. Chest 133(Suppl):381–453
Geerts WH, Heit JA, Clagett GP et al. (2001) Prevention of venous thromboembolism. Chest 119:132–175
Anderson FA Jr, Wheeler HB, Goldberg RJ et al. (1992) The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 152:1660–1664
Clagett GP, Anderson FA Jr, Geerts W et al. (1998) Prevention of venous thromboembolism. Chest 114(5 Suppl):531S–560S
Biggi F, Randelli F, Della Rocca G et al. (2013) Consenso intersocietario sulla profilassi antitrombotica in chirurgia protesica dell’anca e del ginocchio e nelle fratture del collo femorale: aggiornamento 2013. Lo Scalpello-OTODI 27:47
Calori GM, Colombo M, Mazza E et al. (2014) Megaprosthesis in post-traumatic and peri-prosthetic large bone defects: issue to consider. Injury 45(Suppl 6):S105–S110
Motte S, Samama CM, Guay J et al. (2006) Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis. Can J Anaesth 53(6 Suppl):S68–S79
Di Minno G, Mannucci PM, Tufano A et al. (2005) For the First Ambulatory Screening on Thromboembolism (FAST) study group. J Thromb Haemost 3(7):1459–1466
Anderson FA Jr, Zayaruzny M, Heit JA et al. (2007) Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 82(9):777–782
Kakkar AK, Brenner B, Eriksson BI et al. (2008) Extended duration of rivaroxaban versus short term enoxaparin for the prevention on venous thromboembolism after total hip arthroplasty: a double blind, randomized controlled trial. Lancet 372:29–37
Eriksson BI, Kakkar AK, Turpie AG et al. (2009) Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Jt Surg, Br 91:636–644
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori Emilio Luigi Mazza, Massimiliano Colombo, Simone Mazzola, Alessandra Colombo, Carlo Minoli e Giorgio Maria Calori dichiarano di non avere alcun conflitto di interesse.
Consenso informato e conformità agli standard etici
Tutte le procedure descritte nello studio e che hanno coinvolto esseri umani sono state attuate in conformità alle norme etiche stabilite dalla dichiarazione di Helsinki del 1975 e successive modifiche. Il consenso informato è stato ottenuto da tutti i pazienti inclusi nello studio.
Human and Animal Rights
L’articolo non contiene alcuno studio eseguito su esseri umani e su animali da parte degli autori.
Rights and permissions
About this article
Cite this article
Mazza, E.L., Colombo, M., Mazzola, S. et al. Profilassi del rischio tromboembolico specifico. LO SCALPELLO 29, 261–265 (2015). https://doi.org/10.1007/s11639-015-0140-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11639-015-0140-x